MEPDF.US MediPal Holdings Corporation

Healthcare Health Care Providers & Services USA Stocks
18.66 USD
Close of Nov 17, 2026
16.07 18.71
Market cap
USD 3.82B
P/E
13.9x
P/B
0.99x
ROE
7.4%
Dividend yield
2.95%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is MEPDF.US undervalued?

Graham number
Price18.66
Graham value23.83
Discount21.7%

MEPDF.US trades 21.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MediPal Holdings Corporation fundamental analysis

No fundamental analysis for MediPal Holdings Corporation yet.

MediPal Holdings Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MediPal Holdings Corporation

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materi…

Full company profile